Harbor MedTech said yesterday that it raised nearly $5 million for the regenerative treatments for soft tissue repair it developed. The Irvine, Calif.-based company said 3 unnamed investors participated in the equity round, which aims to raise a total of nearly $8.5 million, according to a regulatory filing. Harbor developed a technique it calls “Bridge” to […]
Harbor Medtech reported raising $2.2 million in a March 8, 2013, regulatory filing:
Company: Harbor Medtech
Raise: $2.2 million
Security: Equity, Options & Warrants
Sales Commission: $0
Finders’ Fees: $0
Orthopedic technology company Small Bone Innovations Inc. landed a $43 million loan to further sales of its flagship ankle replacement device.
The New York-based company plans to use the credit facility as working capital to drive U.S. growth of its Star total ankle replacement, a non-cemented implant designed to replace arthritic ankle joints in patients with osteoarthritis, post-traumatic arthritis or rheumatoid arthritis.
The system is currently the only mobile-bearing total ankle replacement approved for the U.S. market.
GE Healthcare (NYSE: GE) invested an undisclosed amount into C8 Medisensors, a developer of non-invasive continuous glucose monitors for diabetic patients.
C8 aims to provide glucose monitoring that is "painless, accurate, continuous, noninvasive, and nonintrusive to your life," according to its website.
The San Jose, Calif.-based company’s glucose monitors use light spectroscopy to measure blood glucose levels without the need for frequent finger pricks.